“Patients ‘relieved’ by amyloid scans” 

 

MedPage Today

February 8, 2017

Learn more about a recent research study conducted by UCI MIND Co-Director, Dr. Joshua Grill, and colleagues to better understand patient and caregiver reactions to clinical amyloid imaging.

Read more> more >



Research Suggests Space Travel Affects the Brain

U.S. News & World Report
February 6, 2017

“This is not a deal-breaker,” co-author Charles Limoli, a neurobiologist at the University of California, Irvine, said last fall. “I do not think that during the course of a trip to Mars and back the astronauts will come back with anything remotely similar to full-blown Alzheimer’s. more >



UCI MIND featured on KCAL9/CBS2 2 nights in a row

December 1, 2016

KCAL9/CBS2

If you missed UCI MIND Gala Co-Chairs, Lucy &  Roger Lisabeth, on KCAL 9 last night, tune into CBS 2 Los Angeles tonight at 5pm with Elsa Ramon to hear their powerful story.

Learn more about what the Lisabeths and UCI MIND are doing in the fight against Alzheimer’s disease here. more >



Alzheimer’s research at UCI “ramps up”

screen-shot-2016-10-03-at-9-26-54-pm“UCI MIND takes multipronged approach to finding preventions, cures in effort to avert baby-boom crisis…”

 

 

 

 

 

 

 

 

 


  more >



Investigational antibody treatment yields exciting though preliminary results

September 1, 2016
Nature

A paper published August 31 in Nature, describes that Biogen Idec’s candidate treatment, aducanumab, reduced amyloid-β in the brains of patients with early-stage Alzheimer’s disease. Patients receiving the highest doses of the medicine in the Phase IB trial had the largest reductions in brain amyloid and also declined the least in clinical assessments.

more >


Sept 30 Research Conference – Featured Topic: Frontotemporal Dementia

ftd image

Did you know that frontotemporal dementia (FTD) is more common than Alzheimer’s disease in people younger than 60 years old?

FTD is a cluster of progressive, degenerative brain diseases that result in significant behavior and personality changes, typically before symptoms of memory loss occur. more >



University of California announces UCI as a recipient of UC Cures for Alzheimer’s Disease award

ucal-fb-imageUC Office of the President
July 25, 2016

University of California announces UCI team, led by UCI MIND co-director Dr. Joshua Grill, as a recipient of the UC Cures for Alzheimer’s award. Read more…“Joshua Grill, associate professor in the department of psychiatry and human behavior at UC Irvine, will lead a team to study the effects of high doses of vitamin nicotinamide in reducing tau phosphorylation in patients with Alzheimer’s disease…” more >



Why women are needed in Alzheimer’s prevention studies now more than ever

mariashriver picJuly 19, 2016
MariaShriver.com

UCI MIND Co-Director Dr. Joshua Grill and A4 Study Project Leader Dr. Reisa Sperling work to understand the heavy burden Alzheimer’s disease places on women– and what women can do to help today.

 


  more >



UCI MIND collaborates in developing potential vaccine for Alzheimer’s disease

 

vaccine image

July 13, 2016

HealthCanal

Read about Professor David Cribbs’ global partnership in developing anti-amyloid-beta & anti-tau vaccines with “promise for both preventive & therapeutic approaches in AD.”

more> more >



Dr. Joshua Grill serves as expert for Alzheimer’s Prevention Registry

ask the expert“Dear Dr. Grill,

My Mom is interested in taking part in a “transparent” preclinical trial on Alzheimer’s disease. As part of the study, she would undergo Positron Emission Tomography, also called a PET scan. Because this is a transparent study, I understand she’ll receive the results of this PET scan. more >